Health In Tech, Inc. Research and Development Expense
Health In Tech, Inc. (HIT) reported Research and Development Expense of $875.81 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- Health In Tech, Inc. research and development expense for the quarter ending 2026-06-30 was $875.81K, a 50.33% increase year-over-year.
- Health In Tech, Inc. research and development expense for the quarter ending 2026-03-31 was $920.39K, a 71.17% increase year-over-year.
- Health In Tech, Inc. research and development expense for the quarter ending 2025-12-31 was $213.11K, a 66.37% decline year-over-year.
- Health In Tech, Inc. research and development expense for the quarter ending 2025-09-30 was $235.82K, a 67.18% decline year-over-year.
- Health In Tech, Inc. research and development expense for fiscal 2025 was $1.57M, a 44.23% decline from fiscal 2024.
- Health In Tech, Inc. research and development expense for fiscal 2024 was $2.81M, a 40.36% increase from fiscal 2023.
- Health In Tech, Inc. research and development expense for fiscal 2023 was $2.00M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $875.81K 10-Q · filed 2026-08-13 | $1.80M 10-Q · filed 2026-08-13 | $2.01M derived: sum of 3 quarters · filed 2026-08-13 | $2.25M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $920.39K 10-Q · filed 2026-05-14 | $1.13M derived: sum of 2 quarters · filed 2026-05-14 | $1.37M derived: sum of 3 quarters · filed 2026-05-14 | $1.95M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $213.11K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $448.93K derived: sum of 2 quarters · filed 2026-03-25 | $1.03M derived: sum of 3 quarters · filed 2026-08-13 | $1.57M 10-K · filed 2026-03-25 |
| 2025-09-30 | $235.82K 10-Q · filed 2025-11-12 | $818.43K derived: sum of 2 quarters · filed 2026-08-13 | $1.36M 10-Q · filed 2025-11-12 | $1.99M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $582.61K 10-Q · filed 2026-08-13 | $1.12M 10-Q · filed 2026-08-13 | $1.75M derived: sum of 3 quarters · filed 2026-08-13 | $2.47M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $537.72K 10-Q · filed 2026-05-14 | $1.17M derived: sum of 2 quarters · filed 2026-05-14 | $1.89M derived: sum of 3 quarters · filed 2026-05-14 | $2.59M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $633.65K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.35M derived: sum of 2 quarters · filed 2026-03-25 | $2.05M derived: sum of 3 quarters · filed 2026-03-25 | $2.81M 10-K · filed 2026-03-25 |
| 2024-09-30 | $718.42K 10-Q · filed 2025-11-12 | $1.42M derived: sum of 2 quarters · filed 2025-11-12 | $2.18M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $701.63K 10-Q · filed 2025-08-08 | $1.46M 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $760.20K 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | $2.00M 10-K · filed 2025-03-17 |